The FDA just approved the first new flu treatment in nearly 20 years
October 24, 2018 at 12:46 PM EDT
Genentech's Xofluza, baloxavir marboxil, is meant to treat acute uncomplicated influenza in patients 12 years and older who have had symptoms for no more than 48 hours.
